Shinya Kimura¹, Kiyotaka Yamazaki², Viana Ricardo³, Naohito Inagaki² (1.Hematol/Oncol, Saga Univ., Saga, Japan, 2.Novartis Pharma K.K. Tokyo, Japan, 3.Novartis Pharmaceuticals Corporation, New Jersey, USA)

Shizuka Arai, Takuya Suyama, Misayo Shimizu, Akihiro Kuroda, Atsushi Shinagawa (Hitachi general hospital, Hematology and Oncology)

Michihiro Uchiyama (Dept of Hematol., Suwa Red Cross Hospital, Nagano, Japan)

Akihito Yonezawa, Aiko Ogura, Fumie Iwai, Rie Matsubara, Takashi Onaka (Department of Hematol., Kokura Memorial Hospital, Fukuoka, Japan)

Noriyoshi Iriyama¹, Michihide Tokuhira², Eriko Sato³, Keiji Sugimoto⁴, Tomoiku Takaku⁵, Maho Ishikawa⁶, Tomonori Nakazato⁷, Hiroyuki Fujita⁸, Yuta Kimura², Isao Fujioka⁵, Norio Asou⁶, Norio Komatsu⁵, Masahiro Kizaki², Yoshihiro Hatta¹, Tatsuya Kawaguchi⁹ (1.Hematol & Rheumatol., Nihon Univ., Tokyo, Japan, 2.Saitama Medical Center, Saitama Medical University, Saitama, Japan, 3.Juntendo University Nerima Hospital, Tokyo, Japan, 4.Juntendo University Urayasu Hospital, Urayasu, Japan, 5.Juntendo University School of Medicine, Tokyo, Japan, 6.Saitama Medical University International Medical Center, Saitama, Japan, 7.Yokohama Municipal Citizen's Hospital, Yokohama, Japan, 8.Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan, 9.Kumamoto Health Science University, Kumamoto, Japan)

Kohshi Ohishi¹, Takeshi Sasaki², Naoto Takahashi³, Naoyuki Katayama⁴ (1.Trans. Med. Cell Ther, Mie Univ. Hos., Tsu, Japan, 2.Dep. of Nephro-Urol Surg. and Androl., Mie Univ., Tsu, Japan, 3.Dep. of Hematol, Nephrol., Rheumatol, Akita Univ., Akita, Japan, 4.Dep. of Hematol. and Oncol., Mie Univ., Tsu, Japan)